Evercore ISI Group Maintains Outperform on West Pharmaceutical Servs, Raises Price Target to $480
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
Evercore ISI Group analyst Daniel Markowitz maintains West Pharmaceutical Servs (NYSE:WST) with a Outperform and raises the price target from $440 to $480.
Evercore ISI Group analyst Daniel Markowitz maintains West Pharmaceutical Servs (NYSE:WST) with a Outperform and raises the price target from $440 to $480.